Commerzbank Aktiengesellschaft’s United Therapeutics UTHR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-40,129
| Closed | -$3.2M | – | 739 |
|
|
2019
Q3 | $3.2M | Sell |
40,129
-226
| -0.6% | -$18K | 0.02% | 351 |
|
|
2019
Q2 | $3.15M | Buy |
40,355
+570
| +1% | +$44.5K | 0.02% | 343 |
|
|
2019
Q1 | $4.67M | Hold |
39,785
| – | – | 0.04% | 272 |
|
|
2018
Q4 | $4.33M | Hold |
39,785
| – | – | 0.04% | 277 |
|
|
2018
Q3 | $5.09M | Hold |
39,785
| – | – | 0.04% | 273 |
|
|
2018
Q2 | $4.5M | Hold |
39,785
| – | – | 0.04% | 287 |
|
|
2018
Q1 | $4.47M | Hold |
39,785
| – | – | 0.05% | 274 |
|
|
2017
Q4 | $5.89M | Hold |
39,785
| – | – | 0.07% | 231 |
|
|
2017
Q3 | $4.66M | Hold |
39,785
| – | – | 0.06% | 238 |
|
|
2017
Q2 | $5.16M | Sell |
39,785
-1,080
| -3% | -$140K | 0.09% | 191 |
|
|
2017
Q1 | $5.53M | Sell |
40,865
-342
| -0.8% | -$46.3K | 0.08% | 192 |
|
|
2016
Q4 | $5.91M | Sell |
41,207
-444
| -1% | -$63.7K | 0.09% | 183 |
|
|
2016
Q3 | $4.92M | Sell |
41,651
-441
| -1% | -$52.1K | 0.08% | 204 |
|
|
2016
Q2 | $4.46K | Sell |
42,092
-568
| -1% | -$60 | 0.03% | 247 |
|
|
2016
Q1 | $4.75M | Sell |
42,660
-263
| -0.6% | -$29.3K | 0.04% | 241 |
|
|
2015
Q4 | $6.72M | Buy |
42,923
+382
| +0.9% | +$59.8K | 0.05% | 202 |
|
|
2015
Q3 | $5.58M | Sell |
42,541
-694
| -2% | -$91.1K | 0.04% | 217 |
|
|
2015
Q2 | $7.52M | Buy |
43,235
+1,650
| +4% | +$287K | 0.04% | 229 |
|
|
2015
Q1 | $7.17M | Sell |
41,585
-35
| -0.1% | -$6.04K | 0.04% | 251 |
|
|
2014
Q4 | $5.39M | Buy |
41,620
+3,266
| +9% | +$423K | 0.03% | 333 |
|
|
2014
Q3 | $4.93M | Buy |
38,354
+14,052
| +58% | +$1.81M | 0.02% | 447 |
|
|
2014
Q2 | $2.15M | Buy |
24,302
+12,750
| +110% | +$1.13M | 0.01% | 624 |
|
|
2014
Q1 | $1.09M | Sell |
11,552
-679
| -6% | -$63.8K | ﹤0.01% | 743 |
|
|
2013
Q4 | $1.26M | Buy |
12,231
+7,966
| +187% | +$817K | 0.01% | 714 |
|
|
2013
Q3 | $336K | Sell |
4,265
-1,534
| -26% | -$121K | ﹤0.01% | 978 |
|
|
2013
Q2 | $382K | Buy |
+5,799
| New | +$382K | ﹤0.01% | 999 |
|